Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom

31 January, 2026 | Saturday

Helsinn and Immedica enter exclusive partnership for commercialisation of cancer supportive care products in core European markets

Helsinn Group (“Helsinn”), a fully integrated global biopharma company with a track record of over forty years of commercial execution and a st...

January 24, 2023 | Tuesday | News

Waterdrop and Jemincare Collaborate on the "Digital Service Platform for CKD Patients"

Featuring both online and offline service modules ranging from follow-up visits and consultation with doctors to interpretation of data reports and popular...

January 05, 2023 | Thursday | News

27
28
29
30
31
32
33
34
35
36

Partner Content

Idorsia Initiates Phase 2 Trial of First-in-Class Oral CCR6 Antagonist in Psoriasis
07 January, 2026
Fagron Completes Acquisition of Purifarma in Brazil
07 January, 2026
FUJIFILM Biosciences Name Change Takes Effect As Life Sciences Group Restructuring Moves Into Execution
06 January, 2026
Hoth Therapeutics Files Two U.S. Provisional Patents to Establish Oncology-Focused Dermatology Platform
06 January, 2026
MindRank Initiates Pivotal Phase III Trial for AI-Designed Oral GLP-1 Candidate MDR-001
07 January, 2026
Eisai and Biogen Secure NMPA Acceptance for Subcutaneous LEQEMBI in China
07 January, 2026

BioPharma BreakThrough's

SciSparc-Backed NeuroThera Secures Israeli Patent for Opioid–N-Acylethanolamine Combination Therapy
01 January, 2026
Palisade Bio Secures Japanese Patent for Gut-Targeted PDE4 Inhibitor PALI-2108
01 January, 2026
Vanda Pharmaceuticals’ Tradipitant (NEREUS™) Approved by FDA for Motion-Induced Vomiting
01 January, 2026
Tiger BioSciences Strengthens Clinical Leadership With Expanded Evidence-Based Research in 2025
01 January, 2026
Transcenta Therapeutics Enters Strategic Bioprocessing Collaboration With EirGenix
31 December, 2025
Mabwell Doses First Patient in World’s First Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring
01 January, 2026

Editor Picks

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2026 Biopharma Boardroom. All Rights Reserved.